iElastance vs Nerbio iTOF

iElastance estimates left ventricular end-systolic elastance (Ees), effective arterial elastance (Ea) and their ratio, ventricular–arterial coupling (VAC), from six values you already have at the bedside: cuff pressures, a standard echocardiogram and two systolic time intervals. No catheter, no extra equipment. FREE • Single-beat calculator (Chen et al., J Am Coll Cardiol 2001): systolic and diastolic pressure, ejection fraction, stroke volume, pre-ejection and total ejection time. • Results update as you type, with checks on impossible values. • "How to measure" guide with diagrams of the method of disks and of systolic times on the LVOT pulsed Doppler. IELASTANCE PREMIUM • Pressure–volume diagram: ESPVR and Ea lines, stroke volume, ESP, EDV, ESV and V0. • Cases: keep your 10 most recent cases, each with as many measurements as you need (baseline, after fluids, after a vasopressor or inotrope…). • Trends of VAC, Ea and Ees over time. • PDF report with results, diagrams, measurement table, trends, method and reference, ready to print or share. • Archive export and import to move your cases to another device. PRIVATE BY DESIGN No account, no analytics, no advertising. Cases and reports stay on your device. SUBSCRIPTION iElastance Premium is an auto-renewing yearly subscription with a 7-day free trial for new subscribers. Payment is charged to your App Store account at confirmation of purchase after the trial. The subscription renews automatically unless cancelled at least 24 hours before the end of the current period; manage or cancel it in your account settings. Terms of Use (Apple standard EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Privacy Policy: https://ielastance.sonable.app/privacy-app.html FOR HEALTHCARE PROFESSIONALS iElastance is intended for physicians and healthcare professionals in intensive care, anaesthesia and cardiology. Results are estimates from a published model and support, never replace, clinical judgement. It does not provide diagnoses or treatment recommendations.

Nerbio’s iTOF® app works with the iTOF device; an FDA cleared, quantitative neuromuscular transmission (NMT) monitor for remote monitoring of neuromuscular blocking agents (NMBAs). The iTOF app is designed to make patient monitoring safer, easier to use, and more accurate than ever. The iTOF is the first mobile device-managed, quantitative monitor of NMBAs. The combination of the app and Bluetooth-connected stimulator device allows precise, automated quantitative monitoring of the level of neuromuscular block. Wireless control also improves caregiver safety while maintaining a high-level of patient care. The iTOF system is recommended by leading anesthesiologists and used around the world for accurate NMBA monitoring. ------------------------------- NOTE: This app requires the iTOF device hardware to perform monitoring. Contact nerbio.com for information. iTOF is a registered trademark of Nerbio Medical Software Platforms, Inc. San Jose, California USA. ------------------------------- NOTE: Nerbio’s iTOF is authorized for use in the following countries: USA CHILE COLOMBIA INDIA -------------------------------